John M. Lambert
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 52
- Immunology 48
- Toxin Mechanisms and Immunotoxins 39
- Co-authors
- Ravi Chari (11 shared papers)Walter A. Blättler (26 shared papers)Victor S. Goldmacher (27 shared papers)Robert R. Traut (10 shared papers)Peter D. Senter (5 shared papers)Robert J. Lutz (13 shared papers)Anna Berkenblit (1 shared paper)Charles Morris (1 shared paper)
- Journals
- Biochemistry (8 papers)Blood (8 papers)Cancer Research (7 papers)Journal of Biological Chemistry (6 papers)Biochemical Journal (4 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
John M. Lambert
128 papers receiving 7.8k citations
John M. Lambert's Hit Papers
Peers
Comparison fields: 5 of 144
- Radiology, Nuclear Medicine and Imaging 3.9k
- Oncology 4.0k
- Biotechnology 797
- Immunology 1.8k
- Molecular Biology 3.4k
Countries citing papers authored by John M. Lambert
This map shows the geographic impact of John M. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Lambert more than expected).
Fields of papers citing papers by John M. Lambert
This network shows the impact of papers produced by John M. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Lambert. The network helps show where John M. Lambert may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Lambert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate Hit paper breakdown → | 2008 | 1259 |
| 2 | Antibody–drug conjugates come of age in oncology Hit paper breakdown → | 2023 | 460 |
| 3 | Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer Hit paper breakdown → | 2014 | 400 |
| 4 | 2005 | 280 | |
| 5 | 2002 | 258 | |
| 6 | 2018 | 245 | |
| 7 | 2017 | 221 | |
| 8 | 2016 | 196 | |
| 9 | 1988 | 173 | |
| 10 | 1978 | 161 | |
| 11 | 2015 | 160 | |
| 12 | 1994 | 159 | |
| 13 | 2011 | 152 | |
| 14 | 2011 | 150 | |
| 15 | 2003 | 146 | |
| 16 | 1996 | 146 | |
| 17 | 2012 | 134 | |
| 18 | 2011 | 131 | |
| 19 | 1985 | 123 | |
| 20 | 2005 | 121 |
About John M. Lambert
John M. Lambert is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Oncology, Molecular Biology and Biotechnology, having authored 129 papers that have together received 8.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (52 papers), Toxin Mechanisms and Immunotoxins (39 papers), HER2/EGFR in Cancer Research (32 papers), Transgenic Plants and Applications (24 papers), CAR-T cell therapy research (14 papers), RNA and protein synthesis mechanisms (12 papers), Glycosylation and Glycoproteins Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.9k citations), Oncology (4.0k citations), Biotechnology (797 citations), Immunology (1.8k citations) and Molecular Biology (3.4k citations). John M. Lambert has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ravi Chari, Walter A. Blättler, Victor S. Goldmacher, Robert R. Traut, Peter D. Senter, Robert J. Lutz, Anna Berkenblit, Charles Morris, Alain Beck and Charles Dumontet. Their work appears in journals such as Biochemistry, Blood, Cancer Research, Journal of Biological Chemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.